Healgen Scientific is dedicated to enhancing global health through the development and provision of high-quality healthcare products and services. The company has established a strong presence in the healthcare industry, with over 16 years of experience and a workforce of approximately 3,000 employees worldwide. Their product offerings include a range of diagnostic tests, notably the COVID-19/Flu A&B Rapid Antigen Test, which has received Emergency Use Authorization. Additionally, Healgen's products have been recognized in over 100 articles in the past three years, highlighting their impact and relevance in the healthcare sector.

The company specializes in various diagnostic technologies, including Fluorescent In Situ Hybridization (FISH) probes, which are used for detecting specific genetic abnormalities in cell and tissue samples. Their extensive catalog includes numerous FISH probe kits designed for hematological applications, such as the detection of chromosomal translocations and gene fusions associated with various cancers. Healgen's commitment to innovation is further demonstrated by their recent certifications, including IVDD CE certification for their colloidal gold and fluorescent products, ensuring compliance with international quality standards. This focus on advanced diagnostic solutions positions Healgen Scientific as a key player in the global healthcare landscape.

United States

Healgen Scientific is a leading global IVD developer and manufacturer focused on delivering life-changing diagnostic products for patients worldwide. For over 17 years, we have strived to provide world-class products and services across multiple healthcare sectors, such as Infectious Diseases, Toxicology, Fertility & Women's Health, Oncology, Cardiovascular, Metabolism, and more. As a highly trusted healthcare partner for over 140 facilities, we develop state-of-the-art devices that exceed industry standards and redefine healthcare, and our portfolio spans multiple testing platforms.

Healgen Scientific

Company Details